PMV Pharmaceuticals, Inc.
PMVP
$1.56
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 21.58% | -9.53% | -1,648.56% | -14.18% | -45.98% |
| Total Depreciation and Amortization | -15.38% | -91.64% | -91.40% | -89.78% | -89.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -83.48% | -17.65% | -25.37% | -25.61% | 383.57% |
| Change in Net Operating Assets | -99.10% | -55.87% | 193.55% | 29.39% | -37.39% |
| Cash from Operations | -3.17% | -17.70% | -1,045.31% | -12.86% | -37.87% |
| Capital Expenditure | 73.21% | 200.00% | -175.00% | 99.33% | 71.57% |
| Sale of Property, Plant, and Equipment | -100.00% | -96.55% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 143.59% | -29.64% | 371.29% | 7.32% | 416.94% |
| Cash from Investing | 138.17% | -29.74% | 372.92% | 9.74% | 399.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 127.91% | -- | -26.95% | -- | -40.28% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 127.91% | -- | -26.95% | -- | -40.28% |
| Foreign Exchange rate Adjustments | 90.91% | -50.00% | -116.67% | 120.59% | -132.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 118.80% | -2,842.96% | -927.29% | 5.20% | 38.99% |